
Eighteen-year-old Evan Morris of Saint Paul, Minnesota, has built a low-cost system that detects seizure-like activity in genetically modified worms and responds with ultrasound. The Society for Science says his closed-loop system…
Eighteen-year-old Evan Morris of Saint Paul, Minnesota, has built a low-cost system that detects seizure-like activity in genetically modified worms and responds with ultrasound. The Society for Science says his closed-loop system reduced seizure recurrence by 70.1% and overall seizure activity by nearly 30% in experiments. Morris received the $10,000 Mary Sue Coleman Award for Life Science Innovation & Impact at the 2026 Regeneron International Science and Engineering Fair, and won first place in Cellular and Molecular Biology.
The system uses gene editing, computer-controlled detection and sonogenetics, which uses ultrasound to influence modified cells. Its value lies in testing stimulation settings quickly in a living model, not in treating epilepsy. Further research is needed before the approach can be assessed in more complex organisms or humans.
The exaggerated version is that a teenager has found an epilepsy cure. The lazy dismissal is that results in worms have no value. Both miss the point. This is an early research platform that may reduce the time and cost of testing brain-stimulation settings, but its 70.1% figure comes from a controlled worm model, not patients. The meaningful test will be whether the method produces reliable results in more complex biological systems.
Source: timesofindia.indiatimes.com
This story was synthesised by AI from the source linked above.